Advertisement

Effects of S-adenosylhomocysteine and Analogs on Epstein-Barr Virus (EBV)-Induced Transformation, EBV DNA Methylation and Gene Expression

  • Gerald Fronko
  • Earl Henderson
  • Brian Wu
  • Walter Long
Part of the Experimental Biology and Medicine book series (EBAM, volume 15)

Abstract

EBV DNA becomes increasingly methylated with time following cell transformation (1) while hypomethylation has been associated with expression of viral genes (2). S-adenosylhomocysteine (SAH), a product of the S-adenosylmethionine transmethylation reaction, acts as a competitive inhibitor of DNA methyltransferases (3). In the present study SAH and analogs, sinefungin (SF) and 5′-deoxy-5′-S-isobutyladenosine (SIBA), as well as 5-azacytidine, which inhibits methylation of nascent DNA (4), were utilized in studies to determine the role of DNA methylation in the regulation of Epstein-Barr virus (EBV) functions such as transformation of human peripheral blood lymphocytes (PBL) and gene expression in lymphoblastoid cell lines. SF and SIBA, but not SAH, inhibited EBV-induced transformation of human PBLs. Indirect immunofluorescence and flow cytometric analyses revealed a significant increase in viral capsid antigen expression in lymphoblastoid cell lines following exposure to the analogs SF and SIBA, but not SAH.

Keywords

Lymphoblastoid Cell Line Human Peripheral Blood Lymphocyte Transmethylation Reaction Human PBLs HpaII Digestion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kintner, C., & B. Sugden, J. Virol. 38:305–316 (1981).PubMedGoogle Scholar
  2. 2.
    Szyf, M., L. Eliasson, V. Mann, G. Klein, & A. Razin, Proc. Natl. Acad. Sci., USA 82:8090–8094 (1983).CrossRefGoogle Scholar
  3. 3.
    Cantoni, G., & A. Razin (eds) Biochemistry and Biology of DNA Methylation (Alan R. Liss, Inc., New York, 1985).Google Scholar
  4. 4.
    Ben-Sasson, S., & G. Klein, Int. J. Cancer 28:131–135 (1981).PubMedCrossRefGoogle Scholar
  5. 5.
    Long, W., G. Fronko, R. Lindemeyer, B. Wu, & E. Henderson, J. Virol, in press (1986).Google Scholar
  6. 6.
    Brandsma, J., & G. Miller, Proc. Natl. Acad. Sci., USA 77:6851–6855 (1980).PubMedCrossRefGoogle Scholar
  7. 7.
    Rabson, M., L. Heston, & G. Miller, Proc. Natl. Acad. Sci., USA 80:2762–1766 (1983).PubMedCrossRefGoogle Scholar
  8. 8.
    Takada, K., S. Norio, S. Sakuma, & Y. Ono, J. Virol. 57:1016–1022 (1986).PubMedGoogle Scholar
  9. 9.
    Lieberman, P., P. O’Hare, G. Hayward, & S. Hayward, J. Virol. 60:140–148 (1986).PubMedGoogle Scholar

Copyright information

© The Humana Press Inc. 1987

Authors and Affiliations

  • Gerald Fronko
    • 1
  • Earl Henderson
    • 1
  • Brian Wu
    • 2
  • Walter Long
    • 1
  1. 1.Department of Microbiology and ImmunologyTemple University School of MedicinePhiladelphiaUSA
  2. 2.Flow Cytometry LaboratoryAlbert Einstein Medical CenterPhiladelphiaUSA

Personalised recommendations